
    
      The primary objective of the study was to investigate the efficacy of Octagam® 10% in
      correcting platelet count. The blood count as well as laboratory chemistry were checked
      repeatedly up to day 21.

      The secondary objective of the study was to investigate the safety of Octagam® 10%. Safety
      was assessed by monitoring vital signs, evaluating adverse events, assessing laboratory
      parameters, and by viral safety testing.
    
  